Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Cancer Genome Atlas

Cancer Genome Atlas The National Cancer Institute and the National Human Genome Research Institute announced that they will begin sequencing the genes of 3 cancers—lung, brain (glioblastoma), and ovarian cancer—in the pilot phase of The Cancer Genome Atlas (TCGA) project (http://cancergenome.nih.gov). TCGA, launched last December, is a collaborative 3-year pilot project to test the feasibility of using large-scale genomic analysis technologies to determine the important genetic changes involved in cancer. Lung, brain, and ovarian cancers were selected first because of availability of specimens that met TCGA's scientific, technical, and ethical requirements. The Lung Cancer Tissue Bank of the Cancer and Leukemia Group B clinical trials group, which is housed at the Brigham and Women's Hospital, in Boston, the M.D. Anderson Cancer Center, in Houston, and the Gynecologic Oncology Group tissue bank at the Children's Hospital of Ohio State University, in Columbus, will provide the specimens. TCGA will ultimately provide researchers with data that might be used to develop new targeted diagnostics, therapeutics, and preventives for different types of cancer. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Cancer Genome Atlas

JAMA , Volume 296 (16) – Oct 25, 2006

Cancer Genome Atlas

Abstract

The National Cancer Institute and the National Human Genome Research Institute announced that they will begin sequencing the genes of 3 cancers—lung, brain (glioblastoma), and ovarian cancer—in the pilot phase of The Cancer Genome Atlas (TCGA) project (http://cancergenome.nih.gov). TCGA, launched last December, is a collaborative 3-year pilot project to test the feasibility of using large-scale genomic analysis technologies to determine the important genetic changes involved in...
Loading next page...
 
/lp/american-medical-association/cancer-genome-atlas-w5B6KnuHtR
Publisher
American Medical Association
Copyright
Copyright © 2006 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.296.16.1958-d
Publisher site
See Article on Publisher Site

Abstract

The National Cancer Institute and the National Human Genome Research Institute announced that they will begin sequencing the genes of 3 cancers—lung, brain (glioblastoma), and ovarian cancer—in the pilot phase of The Cancer Genome Atlas (TCGA) project (http://cancergenome.nih.gov). TCGA, launched last December, is a collaborative 3-year pilot project to test the feasibility of using large-scale genomic analysis technologies to determine the important genetic changes involved in cancer. Lung, brain, and ovarian cancers were selected first because of availability of specimens that met TCGA's scientific, technical, and ethical requirements. The Lung Cancer Tissue Bank of the Cancer and Leukemia Group B clinical trials group, which is housed at the Brigham and Women's Hospital, in Boston, the M.D. Anderson Cancer Center, in Houston, and the Gynecologic Oncology Group tissue bank at the Children's Hospital of Ohio State University, in Columbus, will provide the specimens. TCGA will ultimately provide researchers with data that might be used to develop new targeted diagnostics, therapeutics, and preventives for different types of cancer.

Journal

JAMAAmerican Medical Association

Published: Oct 25, 2006

Keywords: cancer,genome

There are no references for this article.